1 BTC
=
- USD
NanoViricides Inc.
As of June 22, 2026 at 08:12 UTC
Chart
About NanoViricides Inc.
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.
NNVC in Bitcoin terms
NanoViricides Inc. is tracked on Roxom Terminal for users who want to follow and trade global stocks in a Bitcoin-denominated market environment.
- NanoViricides Inc. is categorized under PHARMACEUTICAL PREPARATIONS.
- BTC-denominated charting frames stock performance against Bitcoin instead of fiat alone.
- The global terminal hub links individual stock pages into a crawlable BTC-native market map.
Market Statistics
Trading Metrics
How to Buy NNVC
Create Your Account
Sign up, deposit BTC, and transfer it to your Unified Trading Account. It only takes a moment.
Start Your Trade
From Terminal, click Trade Now on the asset you want to buy. You'll be purchasing its tokenized asset.
Buy NNVC
Enter the amount and confirm your purchase. That's it! You'll see the impact of the trade in your Unified Trading Account.
New to Tokenized Assets? Learn more in our Help Center.
Latest News
5 articlesThe article discusses two small-cap biotech companies with high-risk, high-potential investment opportunities: Mainz Biomed and NanoViricides. Both companies are developing innovative medical technologies but face significant financial challenges and are pre-revenue.
Gainers CytoMed Therapeutics Limited (NASDAQ: GDTC) shares surged 109.2% to $7.30 in pre-market trading after gaining 9% on Monday. Better Therapeutics, Inc. (NASDAQ: BTTX) shares gained 51.1% to $1.36 in pre-market trading after the FDA approved the company's AspyreRx prescription-only digital therapeutic treatment to provide cognitive behavioral therapy to adult patients with type 2 diabetes. Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares rose 42.2% to $0.1450 in pre-market trading after declining around 14% on Monday. Trinity Place Holdings Inc. (NYSE: TPHS) gained 24.1% to $0.6790 in pre-market trading after declining around 15% on Monday. TC Biopharm (Holdings) Plc (NASDAQ: TCBP) shares rose 20.8% to $0.54 in pre-market trading. NanoViricides, Inc. (NYSE: NNVC) rose 19.9% to $1.69 in pre-market trading. NanoViricides reported effectiveness of antiviral clinical drug candidate NV-387 in an animal model of lethal lung infection with respiratory syncytial virus. Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) shares climbed 18.2% to $5.86 in pre-market trading. Acumen Pharmaceuticals recently announced it ...
SHELTON, Conn., May 04, 2023 (GLOBE NEWSWIRE) -- (via IBN) -- NanoViricides, Inc. (NYSE American: NNVC) (the “Company”), a clinical stage global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, announces that Anil R. Diwan, Ph.D., President of the Company will be presenting at The Inaugural EF Hutton Global Conference, which will be held on May 10-11, 2023, at the Plaza Hotel in the heart of New York City. NanoViricides is presenting on May 10th.
UBS cut the price target for Honeywell International Inc. (NASDAQ: HON) from $193 to $185. UBS analyst Chris Snyder maintained a Sell rating. Honeywell shares fell 0.2% to $191.99 in pre-market trading. Credit Suisse raised the price target for uniQure N.V. (NASDAQ: QURE) from $51 to $55. Credit Suisse analyst Judah Frommer maintained an Outperform rating on the stock. uniQure shares jumped 5.2% to close at $21.00 on Monday. Piper Sandler cut the price target for Dollar General Corporation (NYSE: DG) from $288 to $275. Piper Sandler analyst Peter Keith maintained an Overweight rating. Dollar General shares gained 1.4% to $219.11 in pre-market trading. EF Hutton slashed the price target for NanoViricides, Inc. (NYSE: Full story available on Benzinga.com
Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) surged 109.2% to settle at $50.43 on Thursday after the company, and Amgen, announced an agreement under which Amgen will acquire the company for $52 per share in cash. Onion Global Limited (NYSE: OG) jumped 90.6% to close at $0.7624 on Thursday. InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares surged 81% to close at $8.00 on Thursday after gaining over 12% on Wednesday. Minerva Neurosciences, Inc. (NASDAQ: NERV) gained 75.4% to close at $4.70. Missfresh Limited (NASDAQ: MF) shares climbed 51.7% to close at $0.1746 after dropping 7% on Wednesday. NanoViricides, Inc. (NYSE: NNVC) climbed 48.4% to close at $3.65 after the company announced it has begun drug development to combat Monkeypox virus. ZW Data Action Technologies Inc. (NASDAQ: CNET) jumped 44.4% to close at $0.83. ZW Data Action Technologies recently collaborated with Forbes Global Alliance to build the Forbes China Group Digital Collection Platform to launch NFT Products and jointly operate the platform data. Yellow Corporation (NASDAQ: YELL) rose 42.2% to close at $6.70 after the company swung to a profit for the second quarter. Global Blood Therapeutics, Inc. (NASDAQ: GBT) gained 41.4% to close at $47.99 following a report suggesting the company is attracting takeover interest. According to a Bloomberg report, citing people familiar with the matter, some large pharmaceutical companies are looking into a potential deal. Applied DNA Sciences, Inc. (NASDAQ: APDN) climbed 40% to settle at $5.74 as the company reported pricing of $12 million upsized offering. Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) shares jumped 38.1% to settle at $0.1560 after gaining around 9% on Wednesday. Greenpro Capital Corp. (NASDAQ: GRNQ) gained 37.7% to close at $2.41 after climbing around 14% on Tuesday after climbing 28% on Wednesday. Quhuo Limited (NASDAQ: QH) rose 37.6% to close at $0.45. Forge Global Holdings, Inc. (NYSE: FRGE) jumped 33% to close at $6.05. Forge Global is expected to report Q2 financial results on August 11, 2022. Legacy Housing Corporation (NASDAQ: LEGH) jumped 30.4% to close at $17.62 after the company late Wednesday re-stated Q1, Q2 and Q3 interim financial statements for FY21. GeoVax Labs, Inc. (NASDAQ: GOVX) jumped 30.3% to close at $3.57. Geovax Labs posted a Q2 loss of $0.21 per share. GreenLight Biosciences Holdings (NASDAQ: GRNA) shares rose 27.6% to close at $4.16 after jumping over 25% on Wednesday. Samsung Biologics and the company recently announced the completion of the first commercial-scale engineering run for the companies' mRNA production partnership. Waitr Holdings Inc. (NASDAQ: WTRH) jumped 26.9% to settle at $0.4288. Society Pass Incorporated (NASDAQ: SOPA) jumped 26.2% to close at $2.36 after reporting 2Q 2022 and 1H 2022 financial results. Exicure, Inc. (NASDAQ: XCUR) shares gained 25.6% to close at $2.50 after climbing around 27% on Wednesday. BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) rose 23.2% to close at $13.74 after the company reported better-than-expected Q2 EPS and sales results. The company also announced the FDA has lifted its partial clinical hold on the BCX9930 program. Immunic, Inc. (NASDAQ: IMUX) gained 23.1% to close at $4.79 following Q2 results. PagSeguro Digital Ltd. (NYSE: PAGS) gained 22.9% to close at $15.03. TTM Technologies, Inc. (NASDAQ: TTMI) rose 22.4% to close at $16.53 following upbeat Q2 results. Altice USA, Inc. (NYSE: ATUS) surged 21.5% to close at $11.75 following strong quarterly sales. Amesite Inc. (NASDAQ: AMST) gained 20.9% to close at $0.52. Pintec Technology Holdings Limited (NASDAQ: PT) jumped 18.5% to close at $1.2201. Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) jumped 18.8% to close at $0.2642. Precigen, Inc. (NASDAQ: PGEN) jumped 18.4% to settle at $2.12. Digital Brands Group, Inc. (NASDAQ: DBGI) rose 16.7% to close at $0.14. Digital Brands Group, last month, received a determination letter from the Nasdaq stating that the Company has not regained compliance. MercadoLibre, Inc. (NASDAQ: MELI) rose 16.2% to close at $1,034.83 following better-than-expected quarterly ...
